Targeted systemic and peptide radio-ligand therapy for aggressive pituitary tumors and carcinomas
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted systemic and peptide radio-ligand therapy for aggressive pituitary tumors and carcinomas
Authors
Keywords
-
Journal
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-15
DOI
10.1007/s11154-020-09554-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Everolimus in Treatment of Aggressive Prolactin-Secreting Pituitary Adenomas
- (2019) Dongyun Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience
- (2019) G Giuffrida et al. Endocrine Connections
- Pangenomic Classification of Pituitary Neuroendocrine Tumors
- (2019) Mario Neou et al. CANCER CELL
- Immunohistochemical expression of somatostatin receptors SSTR2A and SSTR5 in 299 pituitary adenomas
- (2018) Talia L. Fuchs et al. PATHOLOGY
- Marked response of a hypermutated adrenocorticotropic hormone-secreting pituitary carcinoma to ipilimumab and nivolumab
- (2018) Andrew L Lin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma
- (2018) Felix Behling et al. International Journal of Endocrinology
- Long-Term Survival After Transformation of an Adrenocorticotropic Hormone–Secreting Pituitary Macroadenoma to a Silent Corticotroph Pituitary Carcinoma
- (2018) Lauren E. Rotman et al. World Neurosurgery
- Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas
- (2017) Hélène Lasolle et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
- (2017) Gerald Raverot et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly
- (2017) Eva Venegas-Moreno et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Successful treatment of pituitary carcinoma with concurrent radiation, temozolomide, and bevacizumab after resection
- (2017) Waseem Touma et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Peptide receptor radionuclide therapy of neuroendocrine tumours
- (2016) Tessa Brabander et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- 68Ga DOTATATE PET/CT of Synchronous Meningioma and Prolactinoma
- (2016) Sandip Basu et al. CLINICAL NUCLEAR MEDICINE
- Growth hormone–secreting macroadenoma of the pituitary gland successfully treated with the radiolabeled somatostatin analog 90Y-DOTATATE: case report
- (2016) Joanna Waligórska-Stachura et al. JOURNAL OF NEUROSURGERY
- The Use of 68Ga DOTATATE PET/CT for Diagnostic Assessment and Monitoring of 177Lu DOTATATE Therapy in Pituitary Carcinoma
- (2015) Fuad Novruzov et al. CLINICAL NUCLEAR MEDICINE
- Improvement in Diagnosis of Metastatic Pituitary Carcinoma by 68Ga DOTATATE PET/CT
- (2015) Jianqi Xiao et al. CLINICAL NUCLEAR MEDICINE
- Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide
- (2015) Daniel Bengtsson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Differential somatostatin receptor (SSTR) 1–5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors
- (2015) Katja Kiseljak-Vassiliades et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- CyberKnife Radiosurgery Planning of a Secreting Pituitary Adenoma Performed With 68Ga DOTATATE PET and MRI
- (2014) Andrea d’Amico et al. CLINICAL NUCLEAR MEDICINE
- Letter to the Editor
- (2014) Kalman Kovacs et al. ENDOCRINE PATHOLOGY
- SSTR3 is a putative target for the medical treatment of gonadotroph adenomas of the pituitary
- (2014) Misu Lee et al. ENDOCRINE-RELATED CANCER
- Management of aggressive pituitary adenomas and pituitary carcinomas
- (2014) Anthony Heaney JOURNAL OF NEURO-ONCOLOGY
- Descriptive epidemiology of pituitary tumors in the United States, 2004–2009
- (2014) Haley Gittleman et al. JOURNAL OF NEUROSURGERY
- Angiogenesis in Pituitary Adenomas: Human Studies and New Mutant Mouse Models
- (2014) Carolina Cristina et al. International Journal of Endocrinology
- 68Ga DOTATATE PET/CT in a Rare Coexistence of Pituitary Macroadenoma and Multiple Paragangliomas
- (2013) Rahul Vithalrao Parghane et al. CLINICAL NUCLEAR MEDICINE
- Variability in Quantitative Expression of Receptors in Nonfunctioning Pituitary Macroadenomas - an Opportunity for Targeted Medical Therapy
- (2013) Ambika Babu et al. Endocrine Practice
- Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies
- (2013) Laura Chinezu et al. HUMAN PATHOLOGY
- Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in Somatotroph Adenomas Assessed by Monoclonal Antibodies Was Reduced by Octreotide and Correlated With the Acute and Long-Term Effects of Octreotide
- (2013) Olivera Casar-Borota et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Peptide receptor radionuclide therapy in a patient with disabling non-functioning pituitary adenoma
- (2013) Jan Komor et al. Pituitary
- ACTH-secreting Crooke cell carcinoma of the pituitary
- (2012) Gábor L. Kovács et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Differential Expression of Somatostatin Receptor Subtype 1–5 Proteins in Numerous Human Normal Tissues
- (2012) N. Unger et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment
- (2012) S. Baldari et al. Pituitary
- 68Ga-DOTATOC PET/CT and somatostatin receptor (sst1–sst5) expression in normal human tissue: correlation of sst2 mRNA and SUVmax
- (2011) Christian Boy et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Pituitary Carcinoma: Difficult Diagnosis and Treatment
- (2011) Anthony P. Heaney JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- New targeted therapies in pituitary carcinoma resistant to temozolomide
- (2011) Emmanuel Jouanneau et al. Pituitary
- Anti-VEGF therapy in pituitary carcinoma
- (2011) Leon D. Ortiz et al. Pituitary
- Selective Loss of Somatostatin Receptor 2 in Octreotide-Resistant Growth Hormone-Secreting Adenomas
- (2008) Ursula Plöckinger et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started